scholarly article | Q13442814 |
P356 | DOI | 10.1053/RMED.1999.0733 |
P698 | PubMed publication ID | 10783936 |
P2093 | author name string | Löfdahl CG | |
Jacobson L | |||
Lindgren B | |||
Skoogh BE | |||
Hertzman P | |||
P433 | issue | 3 | |
P921 | main subject | Sweden | Q34 |
asthma | Q35869 | ||
chronic obstructive pulmonary disease | Q199804 | ||
P304 | page(s) | 247-255 | |
P577 | publication date | 2000-03-01 | |
P1433 | published in | Respiratory Medicine | Q2659932 |
P1476 | title | The economic impact of asthma and chronic obstructive pulmonary disease (COPD) in Sweden in 1980 and 1991 | |
P478 | volume | 94 |
Q34309884 | An economic overview of chronic obstructive pulmonary disease |
Q35939354 | Annual costs of chronic obstructive pulmonary disease in Finland during 1996-2006 and a prediction model for 2007-2030. |
Q44272728 | Asthma and allergy: the significance of chronic conditions for individual health behaviour |
Q35863966 | Burden and clinical features of chronic obstructive pulmonary disease (COPD). |
Q36042283 | COPD patients' rights: Can they be won? |
Q28387753 | Cancer risk in hospitalised asthma patients |
Q57777724 | Clinical Outcomes and Cost Analysis of Exacerbations in Chronic Obstructive Pulmonary Disease |
Q44638346 | Cost-utility analysis of a pharmacy-led self-management programme for patients with COPD. |
Q34341891 | Design and analytic considerations in determining the cost-effectiveness of early intervention in asthma from a multinational clinical trial. |
Q43596144 | Direct costs to primary care of chronic bronchitis. Analysis of a prospective study |
Q36980698 | Disproportionate utilization of healthcare resources among veterans with COPD: a retrospective analysis of factors associated with COPD healthcare cost |
Q44442777 | Drug treatment of chronic obstructive pulmonary disease on two levels of patient care: degree of compliance with recommended protocols |
Q73152295 | Economic analysis of the Confronting COPD survey: methodology |
Q42661119 | Economic assessment of adjustable maintenance treatment with budesonide/formoterol in a single inhaler versus fixed treatment in asthma |
Q34381765 | Impact of dropout of female volunteer community health workers: an exploration in Dhaka urban slums |
Q34167388 | Inhaled salmeterol/fluticasone propionate combination. A pharmacoeconomic review of its use in the management of asthma |
Q57128698 | Living with asthma in Sweden--the ALMA study |
Q36859405 | Optimizing economic outcomes in the management of COPD. |
Q35906562 | Present and future costs of COPD in Iceland and Norway: results from the BOLD study |
Q38663315 | Socioeconomic impact of asthma, chronic obstructive pulmonary disease and asthma-COPD overlap syndrome |
Q34801118 | The burden of chronic obstructive pulmonary disease |
Q35205449 | The costs of hospitalization in patients with acute exacerbation of chronic obstructive pulmonary disease. |
Q51681417 | The economic impact of COPD in North America and Europe. Analysis of the Confronting COPD survey. Introduction. |
Q50736607 | [Costs of chronic obstructive pulmonary disease in Spain. Estimation from a population-based study] |
Search more.